TuHURA Biosciences, Inc./NV — Director's Dealing 2017

Jul 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DelMar Pharmaceuticals, Inc. (DMPI)
CIK: 0001498382
Period of Report: 2017-06-30

Reporting Person: Mohr Erich (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-30	Common Stock	J	528	$3.20	Acquired	6638	Direct

Footnotes

F1: The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.